Published in Nature on September 14, 1968
Studies on African Pygmies. IV. A comparative study of the HL-A polymorphism in the Babinga Pygmies and other African and Caucasian populations. Am J Hum Genet (1970) 1.17
A formal genetic analysis of the HL-A system. Am J Hum Genet (1973) 0.86
Tissue matching and early rejection of cadaveric-donor renal allografts: the importance of unidentified donor antigens. Br Med J (1970) 0.84
In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. Clin Exp Immunol (1970) 0.78
Value of prospective tissue typing in kidney transplantation between HL-A identical siblings. Br Med J (1970) 0.78
Leucocyte group compatibility and renal allograft survival in the unmodified canine host. Ann Surg (1970) 0.76
Rapid lymphocytic recognition of histoincompatibility. Changes of the deoxyribonucleoprotein complex in mixed cultures of allogeneic human lymphocytes. J Exp Med (1970) 0.75
The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med (1995) 6.16
Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet (1966) 5.54
HL-A antigens and diabetes mellitus. Lancet (1974) 4.42
HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens (1974) 4.41
HLA and disease 1982--a survey. Immunol Rev (1983) 3.87
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
HL-A and disease associations--a survey. Transplant Rev (1975) 2.87
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet (1999) 2.85
Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A (1999) 2.83
Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group. Lancet (1997) 2.70
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course. Lancet (1973) 2.41
Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet (1995) 2.31
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest (1999) 2.24
Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol (1998) 2.11
HL-A antigens and multiple sclerosis. Lancet (1972) 2.09
Epidemiological studies of diabetes mellitus in Denmark. II. A prevalence study based on insulin prescriptions. Diabetologia (1981) 2.06
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev (1975) 1.97
Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet (1997) 1.92
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
A Danish twin study of manic-depressive disorders. Br J Psychiatry (1977) 1.86
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
Influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol (1997) 1.79
HLA genotype distribution and genetic models of insulin-dependent diabetes mellitus. Ann Hum Genet (1981) 1.78
Genetics of HLA disease association. Annu Rev Genet (1981) 1.74
Human cell-mediated cytotoxicity against modified target cells is restricted by HLA. Nature (1977) 1.69
Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med (1996) 1.67
An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered (1973) 1.64
Studies of the HLA system and insulin-dependent diabetes mellitus. Diabetes Care (1980) 1.63
Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet (1998) 1.62
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence for recombination within and between species. Infect Immun (1998) 1.52
CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol (1998) 1.50
Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet (1994) 1.50
Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. Proc Natl Acad Sci U S A (1997) 1.47
The HL-A7 histocompatibility antigen in sarcoidosis in relation to tuberculin sensitivity. Tissue Antigens (1975) 1.45
HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia (1981) 1.43
Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med (1996) 1.42
Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol (1988) 1.40
Nomenclature for factors of the HLA system, 1998. Tissue Antigens (1999) 1.40
[Transplantation. Blood, bone marrow and solid organs]. Ugeskr Laeger (2000) 1.39
Coronary occlusion in twins. Acta Genet Med Gemellol (Roma) (1971) 1.39
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A (1998) 1.38
The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum (2000) 1.37
Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol (1988) 1.37
HLA--Dw4 and rheumatoid arthritis. Tissue Antigens (1979) 1.36
Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet (1992) 1.35
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
The relation of parental sex and age to recombination in the HL-A system. Hum Hered (1973) 1.30
Human transplantation antigens. Appendix: current methods in histocompatibility testing. Transplant Rev (1969) 1.27
Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA system. Am J Hum Genet (1983) 1.25
The Danish twin register. Acta Genet Med Gemellol (Roma) (1968) 1.25
The incidence and prevalence of familial polyposis coli in Denmark. Scand J Soc Med (1986) 1.25
Congenital generalised bone dysplasias: a clinical, radiological, and epidemiological survey. J Med Genet (1989) 1.24
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci U S A (1999) 1.22
Nomenclature for factors of the HLA system, 2000. Tissue Antigens (2001) 1.21
Data on the HL-A linkage group. Ann Hum Genet (1975) 1.20
Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol (2000) 1.20
HLA and disease. Transplant Proc (1977) 1.19
HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studies. Br J Dermatol (1974) 1.18
Letter: HL-A27 in acute and chronic uveitis. Lancet (1974) 1.18
Nomenclature for factors of the HLA system, 1996. Tissue Antigens (1997) 1.18
Rga (Rodgers) and the HLA region: linkage and associations. Tissue Antigens (1976) 1.16
Letter: HL-A and idiopathic Addison's disease. Lancet (1974) 1.14
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur J Immunol (1994) 1.14
Assignment of the major histocompatibility complex to chromosome No. 6 in a family with a pericentric inversion. Hum Hered (1974) 1.13
The germline repertoire of T-cell receptor beta chain genes in patients with relapsing/remitting multiple sclerosis or optic neuritis. Immunogenetics (1990) 1.13
An HLA map of Europe. Hum Hered (1978) 1.13
Linkage of Chido and HL-A. Tissue Antigens (1974) 1.12
HL-A antigens and diseases. I. Multiple sclerosis. Tissue Antigens (1973) 1.11
The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun (2001) 1.11
MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells. Exp Clin Immunogenet (1998) 1.10
Letter: Lack of antigen response to myxoviruses in multiple sclerosis. Lancet (1973) 1.08
The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis. Genet Epidemiol (1985) 1.08
HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08
Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08
Nomenclature for factors of the HLA system, 2000. Eur J Immunogenet (2001) 1.08
Letter: Salmonella arthritis and HL-A27. Lancet (1974) 1.07
Cystic fibrosis in Denmark 1945 to 1985. An analysis of incidence, mortality and influence of centralized treatment on survival. Acta Paediatr Scand (1988) 1.07
Genetic studies of insulin-dependent diabetes mellitus: segregation and linkage analyses. Tissue Antigens (1982) 1.06
Importance of HLA-D antigens for the cooperation between human monocytes and T lymphocytes. Eur J Immunol (1978) 1.06
NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNF alpha) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol (1989) 1.06
Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells. Proc Natl Acad Sci U S A (1983) 1.05
Psoriasis in an unselected series of twins. Arch Dermatol (1978) 1.04
The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol (1998) 1.04
HLA antigens in Graves' disease. Acta Endocrinol (Copenh) (1977) 1.04
PGM3: HL-A is another linkage in man. Nat New Biol (1971) 1.04
Humoral responses to Pneumocystis carinii in patients with acquired immunodeficiency syndrome and in immunocompromised homosexual men. J Infect Dis (1985) 1.04
Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. Scand J Immunol (1986) 1.03